Table 1

 Baseline clinical characteristics of study participants and comparisons between placebo and probiotic groups

Probiotic, n = 28Placebo, n = 28
*Severity of AD defined according to the SCORAD index: mild <25, moderate 25 to <50, severe >50.19,21
There were no significant differences between the groups.
Gender
    Male14 (50)16 (57)
    Female14 (50)12 (43)
Age (months), mean (SD)11.5 (4.2)10.3 (3.23)
SCORAD index, mean (SD)40.8 (6.8)44.0 (10.4)
Modified SCORAD, mean (SD)32.0 (5.2)34.4 (8.5)
Severity of AD*
    Moderate26 (93)21 (75)
    Severe2 (7)7 (25)
DFIQ score, mean (SD)8.6 (4.5)9.7 (4.9))
Corticosteroid potency
    None, n (%)3 (11)4 (14)
    Mild, n (%)11 (40)10 (36)
    Moderate, n (%)4 (14)5 (18)
    Potent, n (%)10 (36)9 (32)
Total IgE, mean (SD)31.8 (4.3)35.7 (5.95)
RAST to food mix
    Elevated, n (%)20 (71)20 (71)
    Negative, n (%)8 (29)8 (29)
Parental allergy
    Yes, n (%)27 (96)26 (93)
    No, n (%)1 (4)2 (7)
Regularly eat yoghurt
    Yes, n (%)16 (57)12 (43)
    No, n (%)12 (43)16 (57)
Exposure to day care
    Yes, n (%)5 (18)7 (25)
    No, n (%)23 (82)21 (75)